p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

Author:  ["Hedwig Sutterlüty","Eric Chatelain","Alain Marti","Christiane Wirbelauer","Matthias Senften","Uli Müller","Wilhelm Krek"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

The F-box protein p45SKP2 is the substrate-targeting subunit of the ubiquitin–protein ligase SCFSKP2 and is frequently overexpressed in transformed cells. Here we report that expression of p45SKP2 in untransformed fibroblasts activates DNA synthesis in cells that would otherwise growth-arrest. Expression of p45SKP2 in quiescent fibroblasts promotes p27Kip1 degradation, allows the generation of cyclin-A-dependent kinase activity and induces S phase. Coexpression of a degradation-resistant p27Kip1 mutant suppresses p45SKP2-induced cyclin-A-kinase activation and S-phase entry. We propose that p45SKP2 is important in the progression from quiescence to S phase and that the ability of p45SKP2 to promote p27Kip1 degradation is a key aspect of its S-phase-inducing function. In transformed cells, p45SKP2 may contribute to deregulated initiation of DNA replication by interfering with p27Kip1 function.

Cite this article

Sutterlüty, H., Chatelain, E., Marti, A. et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1, 207–214 (1999). https://doi.org/10.1038/12027

View full text

>> Full Text:   p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies

Selective regulation of integrin–cytoskeleton interactions by the tyrosine kinase Src